Advertisement

Internal and Emergency Medicine

, Volume 13, Issue 6, pp 833–835 | Cite as

Weight-loss supplementation and acute liver failure: the case of Garcinia Cambogia

  • Anna LicataEmail author
  • Maria Giovanna Minissale
IM - COMMENTARY

Introduction

The prevalence of obesity, estimated in 600 million of obese people and 1.9 billion of overweight people, is increasing throughout the world [1]. Obesity, as manifestations of the metabolic syndrome, associated with type 2 diabetes, arterial hypertension, and dyslipidemia, results in an increased cardiovascular risk and mortality. In the Western countries, this is commonly related to economic well-being, to the frenetic rhythms, and to a culture lacking in physical exercise. At the same time, the lifestyles of society require a lot of attention to physical appearance, but also to health. Nevertheless, certain goals could rapidly be achieved through different ways that sometimes can be harmful to us. Herbal weight-loss supplements represent an explicative example.

In this context, the paper by Crescioli et al. [2] that shows how dietary supplements containing Garcinia Cambogia(GC), a commonly used weight-loss supplement can cause acute liver injury, fulminant hepatitis,...

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Statement of human and animal rights

This article does not contain any studies with human participants or animals performed by any of the authors.

Conflict of interest

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    WHO World and Health Organization (http://www.epicentro.iss.it). Accessed 23 June 2018
  2. 2.
    Crescioli G, Lombardi N, Bettiol A (2018) Acute liver injury following Garcinia Cambogia weight loss supplementation: case-series and literature review. Intern Emerg Med 10:16Google Scholar
  3. 3.
    Corey R, Werner KT, Singer et al (2016) Acute liver failure associated with Garcinia Cambogia use. Ann Hepatol 15:123–126CrossRefPubMedGoogle Scholar
  4. 4.
    Sharma T, Wong L, Tsai N (2010) Hydroxycut (herbal weight loss supplement) induced hepatotoxycity: a case report and review of literature. Hawaii Med J 69:188–190PubMedPubMedCentralGoogle Scholar
  5. 5.
    Skeie G, Braaten T, Hjartaker A (2009) Use of dietary supplements in the European prospective investigation into cancer and nutrition calibration study. Eur J Clin Nutr. 4:S226–S238CrossRefGoogle Scholar
  6. 6.
    Danan G, Teschke (2015) RUCAM in drug and herb induced liver injury: the update. Int J Mol Sci 17(1):14CrossRefPubMedCentralGoogle Scholar
  7. 7.
    Steven T, Qadri A, Zein NN (2005) Two patients with acute liver injury associated with use of herbal weight loss supplement hydroxycut. Ann Intern Med 142:477–478CrossRefGoogle Scholar
  8. 8.
    Laczek J, Duncan M (2008) Three cases of acute hepatitis in patients taking Hydroxycut® bodybuilding supplement. Am J Gastroenterol 103(S1):143Google Scholar
  9. 9.
    Alempijevic T, Zec S, Milosavljevic T (2017) Drug induced liver injury: do we know everything? World J Hepatol 9:491–502CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Fong TL, Klontz KC, Canas-Coto et al (2010) Hepatotoxycity due to hydroxycut: a case series. Am J Gastroenterol 105:1561–1566CrossRefPubMedGoogle Scholar
  11. 11.
    Smith RJ, Bertilone C, Robertson AG (2016) Fulminant liver failure and transplantation after use of dietary supplements. Med J Aust 204:30–32CrossRefPubMedGoogle Scholar
  12. 12.
    Lunsford KE, Bodzin Reino DC et al (2016) Dangerous dietary supplements: Garcinia Cambogia associated hepatic failure requiring transplantation. World J Gastroenterol 22:10071–10076CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Lucena MI, Andrade RJ, Fernández MC, Spanish Group for the Study of Drug-Induced Liver Disease (Grupo de Estudio para las Hepatopatías Asociadas a Medicamentos (GEHAM)) et al (2006) Determinants of the clinical expression of amoxicillin-clavulanate hepatotoxicity: a prospective series from Spain. Hepatology 44:850–856CrossRefPubMedGoogle Scholar
  14. 14.
    Licata A, Minissale MG, Calvaruso V, Craxi A (2017) A focus on epidemiology of drug induced liver injury: analysis of a prospective color. Eur Rev Med Pharmacol Sci 21:112–121PubMedGoogle Scholar
  15. 15.
    Amadi CN, Orisake OE. Herb-induced injuries in developing nations: an update. Toxics. 2018;6Google Scholar
  16. 16.
    Licata A, Macaluso FS, Craxi A (2013) Herbal hepatotoxicity: a hidden epidemic. Intern Emerg Med 8:13–22CrossRefPubMedGoogle Scholar
  17. 17.
    Garcia-Cortes M, Robles Diaz M, Ortega Alonso A et al (2016) Hepatotoxicity by dietary supplements: a tabular listing and clinical characteristics. Int J Mol Sci 17:537CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Navarro VJ, Barnhart H, Bonkovsky et al (2014) Liver injury from herbal and dietary supplements in the US Drug induced liver injury Network. Hepatology 60:1399–1408CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Zheng EX, Navarro VJ (2015) Liver injury from Herbal Dietary and weight loss supplements: a review. J Clin Transl Hepatol 3:93–98CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    De Smet PA (2002) Herbal remedies. N Engl J Med 347:2046–2056CrossRefPubMedGoogle Scholar
  21. 21.
    Chuah LO, Yeap K, Ho WY et al (2012) In vitro and in vivo toxicity of garcinia or hydroxycitric acid: a review. Evid Based Complement Altern Med.  https://doi.org/10.1155/2012/197920 CrossRefGoogle Scholar
  22. 22.
    Heymsfield SB, Allison DB, Vasselli JR (1998) Garcinia Cambogia (hydroxycitric acid) as a potential antiobesity agent: a randomized controlled trial. JAMA 280:1596–1600CrossRefPubMedGoogle Scholar
  23. 23.
    Onakpoya I, Hung SK, Perry R (2011) The use of Garcinia Cambogia extract (hydroxycitric acid) as a weight loss supplement: a systematic review and meta-analysis of randomised clinical trials. J Obes.  https://doi.org/10.1155/2011/509038 PubMedCrossRefGoogle Scholar
  24. 24.
    Clouatre DL, Preuss HG (2013) Hydroxycitric acid does not promote inflammation or liver toxicity. World J Gastroenterol 19:8160–8162CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Kim YJ, Choi MS, Park YB et al (2013) Garcinia Cambogia attenuates diet induced adiposity but exacerbates hepatic collagen accumulation and inflammation 2013. World J Gastroenterol 19:4689–4701CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Società Italiana di Medicina Interna 2018

Authors and Affiliations

  1. 1.Internal Medicine, Internal Medicine and Hepatology, Department of and Medical Specialities (DIBIMIS)University of PalermoPalermoItaly

Personalised recommendations